Emerging Trends to Drive Point Of Care Infectious Disease Testing Market Growth at 13.6% CAGR Through 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Point Of Care Infectious Disease Testing Market Size Growth Forecast: What to Expect by 2025?
The market encompassing point-of-care testing for infectious diseases has experienced swift expansion lately, projected to increase its valuation from $4.21 billion at the close of 2024 to $4.78 billion by 2025, reflecting a compound annual growth rate (CAGR) of 13.6%. This past period's upward trajectory is primarily fueled by several factors, notably the escalating need for rapid diagnostic methods, a growing prevalence of infectious ailments, heightened public consciousness regarding health matters, greater spending within the healthcare sector, and a marked uptick in the utilization of self-testing and home-based care solutions.

How Will the Point Of Care Infectious Disease Testing Market Size Evolve and Grow by 2029?
Anticipated within the coming years is a swift expansion in the scale of the point of care infectious disease testing market, projected to reach a valuation of $7.96 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.6%. This upward trajectory throughout the projection timeframe is fueled by several key factors, such as escalating requirements for immediate diagnostic results, the growing incidence of communicable diseases, broader deployment in geographically isolated areas and settings lacking sufficient resources, a move toward healthcare delivery decentralization, encouraging governmental policies and financial support. Key developments shaping the period ahead encompass progress in molecular diagnostic techniques, improvements in state-of-the-art point of care testing equipment, breakthroughs in biosensor and detection apparatus, enhancements in mobile health program functionalities, and novel collaborative ventures formed between medical institutions and technology firms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/point-of-care-infectious-disease-testing-global-market-report

What Drivers Are Propelling the Growth of Point Of Care Infectious Disease Testing Market Forward?
An escalation in communicable ailments is anticipated to be the main impetus behind the market expansion for infectious disease diagnostics conducted at the point of care in the foreseeable future. Such illnesses are characterized by their capacity to pass from an infected individual to others via direct touch, airborne particles, or alternative methods of transfer. The primary factor contributing to the heightened frequency of these spreading diseases stems from increased global movement, where the enhanced travel of populations across diverse geographical areas fosters a more rapid and extensive propagation of pathogens. Diagnostics performed immediately where the patient is located streamline the identification and confirmation of outbreaks, allowing for prompt therapeutic intervention and thereby curtailing the spread within populations. Illustratively, data from the UK Health Security Agency indicated that between the fortieth week of 2022 and the fifteenth week of 2023, a total of 1,681 intensive care unit admissions linked to confirmed influenza were documented across 108 National Health Service trusts in England; this contrasts sharply with the preceding influenza season which saw just 182 such admissions across 114 trusts, a figure that later rose to 316 by the thirty-ninth week of 2022. Consequently, the upward trend in infectious disease occurrences is directly stimulating the growth trajectory of the point of care infectious disease testing sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp

Which Emerging Trends Are Transforming the Point Of Care Infectious Disease Testing Market in 2025?
Leading entities within the point-of-care infectious disease diagnostics sector are concentrating their efforts on incorporating novel advancements, specifically unique microfluidic technological frameworks, with the primary aims of elevating the precision of tests, accelerating the turnaround time for findings, and ultimately fostering superior results for patients. This specialized microfluidic apparatus involves bespoke mechanisms adept at managing minuscule liquid quantities at the microscopic level, thereby facilitating analyses that are both swift and economical, which profoundly benefits POC infectious disease screening by permitting immediate, on-site pathogen identification complete with integrated steps for gathering samples, performing the analysis, and issuing the final result, thus boosting diagnostic velocity and availability outside of conventional centralized lab environments. Taking a concrete example, in the month of June in 2023, the diagnostics firm Sysmex Corporation, headquartered in Japan, introduced its PA-100 AST System across Europe; this debut represented the globe's initial point-of-care diagnostic tool capable of directly ascertaining antimicrobial susceptibility. Employing sophisticated microfluidics, this apparatus facilitates the rapid pinpointing of bacterial ailments and the assessment of how effective various antimicrobial agents are, cutting down operational duration considerably when contrasted with established laboratory procedures. The setup consists of a small, benchtop analyzer unit paired with disposable sample cartridges, rendering it perfectly suited for deployment in settings close to the patient, like local medical facilities. Its development directly supports expedited and more precise choices regarding antimicrobial treatment regimens, contributing meaningfully to worldwide initiatives against antimicrobial resistance through elevated diagnostic efficiency.

What Are the Key Segments in the Point Of Care Infectious Disease Testing Market?
The point of care infectious disease testingmarket covered in this report is segmented -

1) By Product: Kits And Reagents; Instruments
2) By Technology: Lateral Flow Immunoassay; Agglutination Test; Flow-through Test Or Immunoconcentration Assay; Molecular Diagnostics; Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing; Clostridium Difficile Point-of-Care Testing; Hepatitis B Virus Point-of-Care Testing; Pneumonia or Streptococcus Associated Infections; Respiratory Syncytial Virus Point-of-Care Testing; Human Papillomavirus Point-of-Care Testing; Influenza Or Flu Point-of-Care Testing; Other Diseases
4) By End Use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Homecare Settings; Other End Users

Subsegments:
1) By Kits And Reagents: Test Kits; Reagents
2) By Instruments: Portable Devices; Automated Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24382&type=smp

Who Are the Key Players Shaping the Point Of Care Infectious Disease Testing Market's Competitive Landscape?
Major companies operating in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton dic*kinson and Company, Quest Diagnostics Incorporated, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc.

What Geographic Markets Are Powering Growth in the Point Of Care Infectious Disease Testing Market?
North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24382

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.